Related Experiment Videos
Trileaflet valve for VAD use with purged sinus.
L Goubergrits1, A Leirner, K Affeld
1Biofluidmechanics Laboratory, Charité, Humboldt University Berlin, Berlin, Germany. leonid.goubergrits@charite.de
Artificial Organs
|June 5, 2003
Summary
A novel ventricle assist device valve design reduces thrombus formation by using a purge flow to increase blood flow in the valve sinus. This computational fluid dynamics study shows the purge flow effectively enhances circulation in these critical areas.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Fluid Dynamics
Background:
- Thromboembolic complications remain a significant challenge in clinical ventricle assist device (VAD) applications.
- Thrombus formation often occurs in the valve sinus region due to stagnant blood flow or recirculation.
- Current VAD valves, even those made of antithrombogenic materials like cross-linked bovine pericardium, are susceptible to thrombus generation in these areas.
Purpose of the Study:
- To introduce and evaluate a novel VAD valve design engineered to mitigate thrombus formation.
- To investigate the efficacy of a purge flow mechanism in preventing stagnant flow within the valve sinus during systole.
- To assess the impact of this design on blood flow dynamics in the valve sinus.
Main Methods:
- Utilized computational fluid dynamics (CFD) to simulate blood flow patterns.
- Introduced a novel valve design incorporating a purge flow system.
- Perforated the valve sinus with a small orifice at its base to direct purge flow.
Main Results:
- The CFD simulations demonstrated that the purge flow effectively increased blood circulation within the valve sinuses.
- The novel design successfully addressed the issue of stagnant flow in the valve sinus during systole.
- This indicates a potential reduction in thrombus formation in critical VAD components.
Conclusions:
- The proposed VAD valve design with a purge flow system is effective in improving blood flow dynamics within the valve sinus.
- This innovative approach shows promise for reducing thromboembolic complications associated with VADs.
- Further clinical investigation is warranted to validate the impact on patient outcomes.